A possible explanation of these conflicting results may be the interaction of GATA3 with steroid hormone receptor signals influencing bladder cancer growth adversely by both stimulatory and inhibitory effects via androgen receptor (AR), estrogen receptor (ER)α and/or ERβ [55, 56]. The gene discussed is GATA3; the disease is urinary bladder carcinoma.